Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by SPCEO1on Nov 23, 2022 1:31pm
223 Views
Post# 35122616

RE:Let's hope

RE:Let's hopeFYI - got a Happy Thanksgiving e-mail from the head of IR. She jokingly mentioned they had been good this year so they are hoping Santa will be good to all of us. I am hoping they have been really, really good and that Santa is in a very good mood! We will know soon enough.

Also, I don't care as much about the Chief Legal Counsel's options. But I do care about how the  CMO handles his.

Biobob wrote: Less than a month left to these expiring options at 30 cents from Marsolais and Lafond... lets hope they don't erase the whole psycholgic effect of the Cantor report and Soleus rationale... lets hope they lend them the money at o% if they are too poor to pay their tax bill.  Lets hope also they deliver the goods before next year... lets hope we can avoid more humiliation from tax selling uninformed and uneducated shareholders and money managers.


<< Previous
Bullboard Posts
Next >>